首页 | 本学科首页   官方微博 | 高级检索  
     


13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study
Authors:Mariane De Montalembert MD  PhD  Miguel R. Abboud MD  Anne Fiquet MD  Adlette Inati MD  Jeffrey D. Lebensburger DO  Normeen Kaddah MD  Galila Mokhtar MD  Antonio Piga MD  Natasha Halasa MD  MPH  Baba Inusa MD  David C. Rees FRCPCH  Paul T. Heath FRCPCH  Paul Telfer MD  Catherine Driscoll MD  Sami Al Hajjar MD  Alberto Tozzi MD  Qin Jiang MS  Emilio A. Emini PhD  William C. Gruber MD  Alejandra Gurtman MD  Daniel A. Scott MD
Affiliation:1. H?pital Necker‐Enfants Malades, Service de Pédiatrie, Paris, France;2. Correspondence to: M. De Montalembert, H?pital Necker‐Enfants Malades, Service de Pédiatrie, 149 rue de Sèvres, Paris 75015, France.;3. E‐mail:;4. Department of Pediatrics and Adolescent Medicine, American University of Beirut, Beirut, Lebanon;5. Vaccine Research, Pfizer Ltd, Tadworth, Berkshire, UK;6. RHUH, Rafic Hariri University Hospital, Beirut, Lebanon;7. University of Alabama at Birmingham, Birmingham, Alabama;8. Pediatric Cairo University Hospital (Abu Elreesh ‐ Almoneera), Egypt;9. Hematology unit, Children Hospital, Ain Shams University, Cairo, Egypt;10. Ospedale San Luigi Gonzaga, Orbassano, Torino University, Italy;11. Vanderbilt University Medical Center, Nashville, Tennessee;12. Evelina Children's Hospital, St Thomas' Hospital, London, UK;13. King's College Hospital, London, UK;14. Vaccine Institute, St Georges, University of London, London, UK;15. Royal London Hospital, London, UK;16. Children's Hospital at Montefiore, Bronx, New York;17. King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia;18. Unità Operativa di Epidemiologia Ospedale Bambino Gesù, Roma, Italy;19. Vaccines, Pfizer Inc, Collegeville, Pennsylvania;20. Vaccine Research, Pfizer Inc, Pearl River, New York
Abstract:
Keywords:13‐valent pneumococcal conjugate vaccine  23‐valent pneumococcal polysaccharide vaccine  hydroxycarbamide  immunogenicity  safety  sickle cell disease
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号